The West Virginia University Rockefeller Neuroscience Institute (RNI) has launched a first-in-the-world clinical trial pairing focused ultrasound treatment with Alzheimer’s antibody drug therapy to a targeted area of the brain, unlocking new potential for the treatment of the disease.